Study guide
10.1 Balloon Angioplasty & Stent Platforms
Registered Cardiovascular Invasive Specialist RCIS
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current RCIS Exam Facts 1.2 Eligibility Pathways & Documentation 1.3 Examination Matrix & Study Plan
2 Pre-Procedural Room Setup & Sterile Technique
2.1 Procedure & Control Room Setup 2.2 Sterile Technique & Universal Precautions 2.3 Personnel Preparation & Cath Lab Roles
3 Pre-Procedural Patient Preparation & Validation
3.1 Preparing the Patient for Invasive Procedures 3.2 Records, Labs, Allergies & Consent 3.3 Time-Out & Universal Protocol
4 Patient Monitoring & Vascular Access
4.1 Intraprocedural Vital Sign Monitoring 4.2 Arterial & Venous Access Sites 4.3 Ultrasound-Guided Access
5 Coronary Anatomy & Left Heart Catheterization
5.1 Coronary Anatomy & Dominance 5.2 Left Heart Catheterization & Coronary Angiography 5.3 Catheter Shapes & Angiographic Projections 5.4 Left Ventriculography & Aortography
6 Right Heart Catheterization & Hemodynamics
6.1 Right Heart Waveforms & Pressures 6.2 Cardiac Output: Fick & Thermodilution 6.3 Valve Area, Bernoulli & Shunt Calculations 6.4 Endomyocardial Biopsy Support
7 ECG & Intracardiac/Intravascular Imaging
7.1 12-Lead ECG in the Cath Lab 7.2 Intracardiac Echocardiography (ICE) 7.3 IVUS & OCT 7.4 Identifying Structures on Cardiac Ultrasound
8 Physiology Assessment & Radiation Safety
8.1 FFR & iFR Studies 8.2 Radiation Safety & ALARA 8.3 Radiographic Equipment Operation 8.4 Image Acquisition & Interpretation
9 Cath Lab Pharmacology
9.1 Anticipating Pharmacologic Needs 9.2 Recognizing Medication Effects & Adverse Reactions 9.3 Anticoagulation & ACT Targets
10 PCI Fundamentals
10.1 Balloon Angioplasty & Stent Platforms 10.2 Coronary Wiring, Lesion Prep & Flow Grades 10.3 Vascular Closure Devices
11 Chapter 11: Complex Coronary Intervention
11.1 CTO, Atherectomy & Alcohol Septal Ablation 11.2 Cardiac Thrombectomy (Mechanical & Aspiration) 11.3 Distal Protection Devices
12 Device Implants & Temporary Support
12.1 Pacemaker, ICD, CRT & Loop Recorders 12.2 Transvenous Temporary Pacemaker 12.3 Pericardiocentesis Support
13 Mechanical Circulatory Support
13.1 IABP & Impella 13.2 ECMO & LVAD Overview for the Cath Lab
14 Peripheral Vascular Interventions
14.1 Peripheral Interventions 14.2 Complex Peripheral Interventions 14.3 Peripheral Thrombectomy & Thrombolysis
15 Structural Heart Interventions
15.1 Nonvalvular Structural Therapies 15.2 Percutaneous Valve Interventions
16 Chapter 16: Emergency Clinical Presentations & Equipment
16.1 STEMI, Cardiogenic Shock & Pulmonary Edema 16.2 Stroke & Neurologic Emergencies in the Lab 16.3 Emergency Equipment Operation
17 Intraprocedural Complications
17.1 Coronary Interventional Complications 17.2 Peripheral & Structural Complications
18 Post-Procedural Activities
18.1 Arterial & Venous Hemostasis 18.2 Access-Site Complications 18.3 Patient Education, Reporting & Transfer of Care
10.1 Balloon Angioplasty & Stent Platforms
Key Takeaways Explain This Topic AI
Plain balloon angioplasty (POBA) dilates plaque but elastic recoil and dissection often require stent implantation for durable results
Drug-eluting stents (DES) combine a metal platform, antiproliferative drug, and polymer carrier to reduce restenosis versus bare-metal stents
Contemporary DES families use limus-class agents (everolimus, zotarolimus, biolimus) on cobalt-chromium or platinum-chromium platforms with durable or bioabsorbable polymers
Stent sizing targets reference vessel diameter (RVD) and lesion length with adequate proximal and distal landing zones beyond the diseased segment
Deployment uses controlled inflation pressure, radiographic confirmation of apposition, and post-dilation with a non-compliant balloon when under-expanded
Last updated: July 2026
10.1 Balloon Angioplasty & Stent Platforms
Quick Answer: Percutaneous coronary intervention (PCI) begins with balloon angioplasty to crack and displace atherosclerotic plaque, but stents are required in most cases to prevent elastic recoil and flow-limiting dissection. Drug-eluting stents (DES) add an antiproliferative drug and polymer to the metal scaffold, dramatically lowering restenosis compared with bare-metal stents (BMS) . RCIS staff must understand sizing (reference vessel diameter and lesion length), deployment technique (position, pressure, angiographic check), and how to assist with contemporary DES platforms used in modern labs.
Balloon Angioplasty: What the Balloon Actually Does
Plain old balloon angioplasty (POBA) uses a non-compliant or semi-compliant balloon inflated within the stenosis to fracture plaque , remodel the vessel wall , and enlarge the luminal diameter. Inflation is performed at controlled atmospheres (atm) while the team watches angiographically for waist resolution , dissection flaps , and slow-flow phenomena.
POBA alone leaves two problems that drove stent adoption:
Elastic recoil — the vessel springs partially back after deflation.
Flow-limiting dissection — intimal tears can create a flap that compromises antegrade flow.
For RCIS support, balloon work means verifying balloon diameter matches reference vessel size , confirming radiopaque markers straddle the lesion before inflation, and having stent inventory and IVUS/OCT readiness if the result is suboptimal. Always note inflation pressure and duration in the record—they matter if a vessel suddenly closes.
Bare-Metal Stents Versus Drug-Eluting Stents
A bare-metal stent (BMS) is a metallic scaffold that tacks dissection and prevents recoil. BMS remain appropriate in select settings (some bifurcations, patients where prolonged DAPT is impossible, certain SVG interventions per lab protocol), but in-stent restenosis from neointimal hyperplasia limits their routine use in native coronaries.
A drug-eluting stent (DES) adds:
Component Function
Stent platform Provides radial strength and immediate lumen gain (stainless steel, cobalt-chromium, platinum-chromium alloys)
- Polymer carrier Holds and releases drug; may be durable or bioabsorbable
- Antiproliferative drug Suppresses smooth muscle proliferation to reduce restenosis
Limus-class agents (sirolimus and derivatives) dominate contemporary DES: everolimus , zotarolimus , and biolimus A9 are the agents RCIS candidates most often encounter on inventory labels.
Contemporary DES Platform Examples
Exact hospital formularies vary, but CCI-relevant platform families include:
Xience / XIENCE Skypoint (Abbott) — cobalt-chromium platform with everolimus and durable polymer; among the most widely implanted DES globally.
Promus Element / Synergy family (Boston Scientific) — platinum-chromium platforms; Synergy uses everolimus with a bioabsorbable PLGA polymer on the abluminal surface (polymer-free abluminal metal after absorption).
Resolute Onyx / Integrity (Medtronic) — cobalt or platinum-chromium platforms with zotarolimus and durable polymer designed for deliverability in tortuous vessels.
Orsiro (Biotronik) — cobalt-chromium stent with sirolimus , bioabsorbable poly-L-lactic acid (PLLA) polymer , marketed for thin-strut deliverability.
RCIS does not choose the stent—that is physician decision—but you open the correct size , inspect expiry and integrity , prime and flush the delivery system per IFU, and capture lot numbers for implant registries.
DES Concepts RCIS Must Know
Dual antiplatelet therapy (DAPT) duration after DES is a medical decision, yet RCIS staff field patient questions. DES reduces restenosis but requires platelet inhibition while endothelialization completes; premature DAPT stop raises stent thrombosis risk—a cath lab emergency.
Stent thrombosis presents as acute closure with chest pain and ST changes; support includes activating the code team , preparing GP IIb/IIIa agents or cangrelor per protocol, and readying aspiration catheters and repeat angiography .
Polymer considerations: durable polymer DES have long track records; bioabsorbable polymer and polymer-free abluminal designs aim to lower chronic inflammation. Exam items may contrast platforms—focus on drug name + platform metal + polymer type .
Deliverability features (thin struts, low crossing profile, flexible connectors) matter when the physician struggles in tortuous or calcified anatomy—have extra support wire and lower-profile DES available per lab matrix.
Stent Sizing: Diameter and Length
Correct sizing balances adequate expansion against edge dissection and geographic miss .
Diameter
Reference vessel diameter (RVD) is estimated by visual angiography or measured with quantitative coronary angiography (QCA), IVUS, or OCT . Stent diameter is typically chosen at or slightly below RVD for most lesions; undersized stents fail to appose the wall; oversized stents risk edge dissection and perforation.
RCIS assists by confirming the stent label diameter matches the verbal order before the back table opens the package.
Length
Stent length must cover the lesion with healthy landing zones proximally and distally—commonly 2–3 mm margins beyond angiographic disease unless imaging defines otherwise. When lesion length exceeds one stent, overlap technique (typically 2–3 mm for same-diameter DES) prevents gaps; document multiple implant serial numbers .
Stent/post-dilatation balloon compatibility: post-dilatation balloons should not exceed stent inner diameter ratings in the IFU; RCIS verifies NC balloon size when ordered after deployment.
Deployment Workflow
A typical DES deployment sequence:
Lesion crossed with guidewire; predilation if needed (see Section 10.2).
Stent crimped on delivery catheter advanced over wire; radiopaque markers aligned with lesion.
Stent positioned with tip parked safely; physician confirms proximal/distal markers relative to branch and disease.
Deployment inflation at manufacturer-specified pressure (often ≥11–14 atm depending on platform) until balloon waist resolves; maintain pressure per IFU.
Deflate slowly , pull balloon while watching for stent migration (rare with modern crimping).
Angiographic result: TIMI flow, dissection at edges, apposition concerns.
Post-dilation with non-compliant balloon at high pressure if under-expanded or under-sized visually; IVUS/OCT when ordered.
RCIS responsibilities: flush the stent lumen , prevent air embolism, hold catheter hub during exchanges, monitor hemodynamics and ECG for ischemia, and verbalize timer requests during prolonged inflation.
Common Deployment Pitfalls
Geographic miss — stent placed short of disease; requires overlap stent or bailout.
Under-expansion — especially in calcified lesions; may need high-pressure NC post-dilatation or atherectomy first.
Edge dissection — may need additional stent or balloon touch-up.
Air embolism — catastrophic; meticulous flushing prevents it.
Balloon Types in PCI Support
- Balloon type Typical use
- Semi-compliant (SC) Predilation; conforms somewhat to vessel shape
- Non-compliant (NC) Post-dilation at high pressure; precise diameter
- Cutting/scoring Vessel preparation in resistant lesions (see 10.2)
Know rated burst pressure and RBP warnings —never exceed IFU limits even if the physician asks without checking.
Documentation and Registries
Record stent manufacturer, model, diameter, length, lot/UDI , deployment pressure, and number of stents . Many labs participate in NCDR CathPCI —incomplete implant logs trigger audit findings.
- Official and Professional Resources
- ACC/AHA/SCAI revascularization guidelines — DES class recommendations and DAPT frameworks
- Manufacturer IFUs for Xience, Synergy, Resolute, Orsiro — deployment pressures and sizing charts
- CCI RCIS examination matrix — interventional equipment and PCI support tasks
Balloon and stent fundamentals are the daily language of the interventional lab. When you can translate RVD, stent length margins, deployment pressure, and DES drug/platform pairs into correct equipment action, you function as a true RCIS-level PCI partner—not merely a circulator.